Researchers from IIT Jodhpur, including Professor Mitali Mukerji, examined transcriptomic data from 106 participants in the Inner Engineering program and reached an unexpected conclusion: the molecular changes after the practice coincide with the profiles of more than 438 drugs. Most notable among them are agents acting on neuroactive ligand-receptor pathways, which influence the balance of excitation and inhibition in the cortex. The work was released as a preprint at the end of 2025 and received widespread media attention in November 2026.
The comparison was carried out using the Connectivity Map, a database that collects gene expression profiles after exposure to thousands of small molecules. The scientists compared the genes whose activity changed at three stages: during the preparatory period, during the eight-day retreat, and three months afterward. The most persistent matches concerned the signaling systems of GABA, the brain's main inhibitory neurotransmitter, and other neuromodulators. It is also interesting that after three months most of the original signatures disappeared, giving way to new ones: the picture turned out to be dynamic rather than fixed.
An additional statistical analysis linked these signatures to published data on how drugs alter cortical excitability, which is measured by transcranial magnetic stimulation (TMS). Classes of medications with a known effect on the cortex turned out to be close to the meditation profiles in the latent feature space. This is precisely a statistical similarity, not proof of a shared mechanism.
It is important to understand the limits of the work. The authors explicitly call it hypothesis-generating: the study itself did not measure neurophysiological parameters, and no causal relationships are asserted. There was also no control group of people without a meditation practice. Moreover, the material on which the analysis is based is blood. In a separate analysis of the same public whole-blood data, it is emphasized that shifts in gene expression mainly reflect circulating immune cells and do not necessarily speak to processes within the central nervous system. To test the hypothesis about the balance of excitation and inhibition, the authors propose experiments combining TMS and EEG.
Prof. Mitali Mukerji Ji (Professor in the Department of Bioscience and Bioengineering at IIT Jodhpur) sent me a paper a few days ago and I have not stopped thinking about it. Her team found that a meditation retreat and a sleeping pill leave a similar mark in the blood. Let me
This pushes toward a revision of the usual division of meditation into "psychological" and "biological." If the same molecular targets respond both to a pill and to eight days of intensive practice, the difference between them may lie not in the mechanism itself but in the route by which the signal reaches those targets.
Imagine a pharmacy shelf where a synthetic key and a natural fingerprint lie side by side, and both fit the same lock in a cell membrane. From this perspective, meditation no longer looks like merely a mental technique but also like a biologically active intervention whose effects can in principle be measured by the same methods as the action of drugs. The image is apt, but it describes a similarity of targets, not a full equivalence of the two routes.
For theories of consciousness that rely on predictive processing and active inference, the result can be read as a hint that interoceptive precision and the weighting of prediction errors may be tuned already at the level of gene transcription. This is still a working hypothesis, but it links subjective experience to specific molecular regulation.
For clinical practice, the authors allow that when meditation is used, it may be necessary to take into account a person's baseline neurochemical profile, and not only their complaints. How stable these molecular shifts are outside a controlled retreat, and whether they can be reproduced in everyday life without special training, is not yet known.




